Open AccessThis article is
- freely available
Biologics in Dermatology
London School of Hygiene and Tropical Medicine, Keppel Street, WC1E 7HT, London, UK
Whipps Cross University Hospital and the Royal London Hospital, Whitechapel, E1 1BB, London, UK
* Author to whom correspondence should be addressed.
Received: 31 January 2013; in revised form: 26 February 2013 / Accepted: 7 April 2013 / Published: 17 April 2013
(This article belongs to the Special Issue Biologics
Abstract: Skin and subcutaneous diseases affect millions of people worldwide, causing significant morbidity. Biologics are becoming increasingly useful for the treatment of many skin diseases, particularly as alternatives for patients who have failed to tolerate or respond to conventional systemic therapies. Biological therapies provide a targeted approach to treatment through interaction with specific components of the underlying immune and inflammatory disease processes. This review article examines the increasing evidence base for biologics in dermatology, including well-established treatments and novel agents.
Keywords: biologics; biological response modifiers; immunopathogenesis; dermatology; skin disease
Citations to this Article
Cite This Article
MDPI and ACS Style
Chandler, D.; Bewley, A. Biologics in Dermatology. Pharmaceuticals 2013, 6, 557-578.
Chandler D, Bewley A. Biologics in Dermatology. Pharmaceuticals. 2013; 6(4):557-578.
Chandler, David; Bewley, Anthony. 2013. "Biologics in Dermatology." Pharmaceuticals 6, no. 4: 557-578.